Session date: 
Friday, July 12, 2019 - 12:00pm to 1:00pm
WDL Building, 2nd Floor, Pathology Administrative Suites
9200 W. Wisconsin Avenue
Room 247
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 


This educational activity is designed to provide our faculty with alternative sources of information and experience on controversial areas in diagnostic pathology that cannot be gleaned from reading the literature or standard textbooks in pathology.  There are many areas in pathology where a uniformly acceptable standard has not yet been established.  Direct interaction with an expert can provide the pathologist with additional insight into more effective ways to handle the issue. 


ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 
Allied Health Professionals
Learning objectives: 

At the conclusion of this activity, learners will be able to:

  • Describe CAR-T cell technology and its role in B-Cell Malignancies

  • Discuss clinical outcomes to date for CD19 CAR-T cell therapy in ALL and NHL

  • Identify future directions in CAR-T cell therapy

Faculty & credentials: 
Planning Committee:
Blake W. Buchan, PhD
Kathleen Bone, PhD
Tamara Giorgadze, MD, PhD
Kenneth A. Iczkowski, MD
Shannon M. Majewski, CMP
Lauren N. Parsons, MD

Nirav Shah, MD

Division of Hematology and Oncology

Froedtert and the Medical College of Wisconsin

All persons in control of content have NO relevant financial relationships to disclose except the following:

Nirav Shah, MD, MSKite PharmaAdvisory Board
Nirav Shah, MD, MSJuno PharmaceuticalsAdvisory Board
Nirav Shah, MD, MSMiltenyi BiotecSpeaker/Research
Nirav Shah, MD, MSCelegeneConsultant
Nirav Shah, MD, MSIncyteConsultant


CME Coordinator Contact Information

Shannon Majewski, CMP
Phone number: 
+1 (414) 805-6976